Anandamida (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anandamida" in Galician language version.

refsWebsite

Global rank Galician rank

50doi.org

2^nd place

7^th place

49nih.gov

4^th place

6^th place

8worldcat.org

5^th place

11^th place

7harvard.edu

18^th place

38^th place

5sciencedirect.com

149^th place

162^nd place

3escholarship.org

1,523^rd place

1,732^nd place

1archive.org

6^th place

8^th place

1lww.com

2,769^th place

5,385^th place

1jci.org

low place

7,856^th place

1nytimes.com

7^th place

32^nd place

1theguardian.com

12^th place

64^th place

1aad.org

low place

1managedhealthcareexecutive.com

low place

aad.org

eposters.aad.org

"AAD ePosters".

archive.org

Mechoulam R, Fride E (1995). "The unpaved road to the endogenous brain cannabinoid ligands, the anandamides". En Pertwee RG. Cannabinoid receptors. Boston: Academic Press. pp. 233–258. ISBN 978-0-12-551460-6.

doi.org

dx.doi.org

Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (decembro de 1992). "Isolation and structure of a brain constituent that binds to the cannabinoid receptor". Science 258 (5090): 1946–1949. Bibcode:1992Sci...258.1946D. PMID 1470919. doi:10.1126/science.1470919.
Martin BR, Mechoulam R, Razdan RK (1999). "Discovery and characterization of endogenous cannabinoids". Life Sciences 65 (6–7): 573–595. PMID 10462059. doi:10.1016/S0024-3205(99)00281-7.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature (Submitted manuscript) 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Wang J, Ueda N (setembro de 2009). "Biology of endocannabinoid synthesis system". Prostaglandins & Other Lipid Mediators 89 (3–4): 112–119. PMID 19126434. doi:10.1016/j.prostaglandins.2008.12.002.
Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V (2009). "The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs". International Review of Neurobiology 85: 57–72. ISBN 9780123748935. PMID 19607961. doi:10.1016/S0074-7742(09)85005-8.
Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA (abril de 2010). "Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality". Life Sciences 86 (15–16): 615–623. PMC 2848893. PMID 19527737. doi:10.1016/j.lfs.2009.06.003.
Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Ellington, Heather C; Cotter, Mary A; Cameron, Norman E; Ross, Ruth A (2002-06-01). "The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats". Neuropharmacology (en inglés) 42 (7): 966–975. ISSN 0028-3908. PMID 12069907. doi:10.1016/S0028-3908(02)00040-0.
Silva, M.; Martins, D.; Charrua, A.; Piscitelli, F.; Tavares, I.; Morgado, C.; Di Marzo, V. (2016-08-01). "Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy". Neuropharmacology (en inglés) 107: 49–57. ISSN 0028-3908. PMID 26965218. doi:10.1016/j.neuropharm.2016.03.007.
Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Pacher P, Bátkai S, Kunos G (setembro de 2006). "The endocannabinoid system as an emerging target of pharmacotherapy". Pharmacological Reviews 58 (3): 389–462. PMC 2241751. PMID 16968947. doi:10.1124/pr.58.3.2.
Piomelli D (xaneiro de 2004). "THC: moderation during implantation". Nature Medicine 10 (1): 19–20. PMID 14702623. doi:10.1038/nm0104-19.
El-Talatini MR, Taylor AH, Konje JC (abril de 2010). "The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle". Fertility and Sterility 93 (6): 1989–1996. PMID 19200965. doi:10.1016/j.fertnstert.2008.12.033.
Rapino C, Battista N, Bari M, Maccarrone M (2014). "Endocannabinoids as biomarkers of human reproduction". Human Reproduction Update 20 (4): 501–516. PMID 24516083. doi:10.1093/humupd/dmu004.
Fuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P (outubro de 2015). "A runner's high depends on cannabinoid receptors in mice". Proceedings of the National Academy of Sciences of the United States of America 112 (42): 13105–13108. Bibcode:2015PNAS..11213105F. PMC 4620874. PMID 26438875. doi:10.1073/pnas.1514996112.
Woodward DF, Liang Y, Krauss AH (febreiro de 2008). "Prostamides (prostaglandin-ethanolamides) and their pharmacology". British Journal of Pharmacology 153 (3): 410–419. PMC 2241799. PMID 17721551. doi:10.1038/sj.bjp.0707434.
De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (xullo de 1998). "The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation". Proceedings of the National Academy of Sciences of the United States of America 95 (14): 8375–8380. Bibcode:1998PNAS...95.8375D. PMC 20983. PMID 9653194. doi:10.1073/pnas.95.14.8375.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Jeffries KA, Dempsey DR, Behari AL, Anderson RL, Merkler DJ (maio de 2014). "Drosophila melanogaster as a model system to study long-chain fatty acid amide metabolism". FEBS Letters 588 (9): 1596–1602. PMC 4023565. PMID 24650760. doi:10.1016/j.febslet.2014.02.051.
McPartland J, Di Marzo V, De Petrocellis L, Mercer A, Glass M (agosto de 2001). "Cannabinoid receptors are absent in insects". The Journal of Comparative Neurology 436 (4): 423–429. PMID 11447587. doi:10.1002/cne.1078.
Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R (xuño de 2013). "Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences". Neuropsychology Review 23 (2): 117–137. PMC 3593817. PMID 23129391. doi:10.1007/s11065-012-9222-1.
Kregiel J, Malek N, Popik P, Starowicz K, Rygula R (febreiro de 2016). "Anandamide mediates cognitive judgement bias in rats". Neuropharmacology 101: 146–153. PMID 26363193. doi:10.1016/j.neuropharm.2015.09.009.
Mallet P, Beninger R (maio de 1996). "The endogenous cannabinoid receptor agonist anandamide impairs memory in rats". Behavioural Pharmacology (en inglés) 7 (3): 276–284. ISSN 0955-8810. doi:10.1097/00008877-199605000-00008.
Calabrese EJ, Rubio-Casillas A (maio de 2018). "Biphasic effects of THC in memory and cognition". European Journal of Clinical Investigation 48 (5): e12920. PMID 29574698. doi:10.1111/eci.12920.
Fantegrossi WE, Wilson CD, Berquist MD (febreiro de 2018). "Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems". Drug Metabolism Reviews 50 (1): 65–73. PMC 6419500. PMID 29385930. doi:10.1080/03602532.2018.1428343.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J (xaneiro de 2020). "Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review". BMC Psychiatry 20 (1): 24. PMC 6966847. PMID 31948424. doi:10.1186/s12888-019-2409-8.
Mahler SV, Smith KS, Berridge KC (novembro de 2007). "Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward". Neuropsychopharmacology 32 (11): 2267–2278. PMID 17406653. doi:10.1038/sj.npp.1301376.
Williams CM, Kirkham TC (xuño de 2002). "Observational analysis of feeding induced by Δ9-THC and anandamide". Physiology & Behavior 76 (2): 241–250. PMID 12044596. doi:10.1016/S0031-9384(02)00725-4.
Natarajan V, Reddy PV, Schmid PC, Schmid HH (agosto de 1982). "N-Acylation of ethanolamine phospholipids in canine myocardium". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 712 (2): 342–355. PMID 7126608. doi:10.1016/0005-2760(82)90352-6.
Cadas H, di Tomaso E, Piomelli D (febreiro de 1997). "Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain". The Journal of Neuroscience 17 (4): 1226–1242. PMC 6793739. PMID 9006968. doi:10.1523/JNEUROSCI.17-04-01226.1997.
Magotti P, Bauer I, Igarashi M, Babagoli M, Marotta R, Piomelli D, Garau G (marzo de 2015). "Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids". Structure 23 (3): 598–604. PMC 4351732. PMID 25684574. doi:10.1016/j.str.2014.12.018.
Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V (maio de 2001). "Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets". Proceedings of the National Academy of Sciences of the United States of America 98 (11): 6402–6406. Bibcode:2001PNAS...98.6402B. PMC 33480. PMID 11353819. doi:10.1073/pnas.101119098.
Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Bátkai S, et al. (maio de 2005). "Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity". The Journal of Clinical Investigation 115 (5): 1298–1305. PMC 1087161. PMID 15864349. doi:10.1172/JCI23057.
Högestätt ED, Jönsson BA, Ermund A, Andersson DA, Björk H, Alexander JP, et al. (setembro de 2005). "Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system". The Journal of Biological Chemistry 280 (36): 31405–31412. PMID 15987694. doi:10.1074/jbc.M501489200.
Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S (setembro de 2006). "Paracetamol: new vistas of an old drug". CNS Drug Reviews 12 (3–4): 250–275. PMC 6506194. PMID 17227290. doi:10.1111/j.1527-3458.2006.00250.x.
Sinning C, Watzer B, Coste O, Nüsing RM, Ott I, Ligresti A, et al. (decembro de 2008). "New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide". Journal of Medicinal Chemistry 51 (24): 7800–7805. PMID 19053765. doi:10.1021/jm800807k.
Kaczocha M, Glaser ST, Deutsch DG (abril de 2009). "Identification of intracellular carriers for the endocannabinoid anandamide". Proceedings of the National Academy of Sciences of the United States of America 106 (15): 6375–6380. Bibcode:2009PNAS..106.6375K. PMC 2669397. PMID 19307565. doi:10.1073/pnas.0901515106.
Oddi S, Fezza F, Pasquariello N, D'Agostino A, Catanzaro G, De Simone C, et al. (xuño de 2009). "Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins". Chemistry & Biology 16 (6): 624–632. PMID 19481477. doi:10.1016/j.chembiol.2009.05.004.
Di Scala C, Fantini J, Yahi N, Barrantes FJ, Chahinian H (maio de 2018). "Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter". Biomolecules 8 (2): 31. PMC 6022874. PMID 29789479. doi:10.3390/biom8020031.
Nicolussi S, Viveros-Paredes JM, Gachet MS, Rau M, Flores-Soto ME, Blunder M, Gertsch J (febreiro de 2014). "Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice". Pharmacological Research 80: 52–65. PMID 24412246. doi:10.1016/j.phrs.2013.12.010.
Cernak I, Vink R, Natale J, Stoica B, Lea PM, Movsesyan V, et al. (May 2004). "The "dark side" of endocannabinoids: a neurotoxic role for anandamide". Journal of Cerebral Blood Flow and Metabolism 24 (5): 564–578. PMID 15129189. doi:10.1097/00004647-200405000-00011.
Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, et al. (maio de 2003). "Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases". The Journal of Neuroscience 23 (10): 4127–4133. PMC 6741091. PMID 12764100. doi:10.1523/JNEUROSCI.23-10-04127.2003.
Schulz, Piotr; Hryhorowicz, Szymon; Rychter, Anna Maria; Zawada, Agnieszka; Słomski, Ryszard; Dobrowolska, Agnieszka; Krela-Kaźmierczak, Iwona (2021-01-26). "What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?". Nutrients (en inglés) 13 (2): 373. ISSN 2072-6643. PMC 7911032. PMID 33530406. doi:10.3390/nu13020373.
Morena, Maria; Aukema, Robert J.; Leitl, Kira D.; Rashid, Asim J.; Vecchiarelli, Haley A.; Josselyn, Sheena A.; Hill, Matthew N. (2019-02-13). "Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety". The Journal of Neuroscience (en inglés) 39 (7): 1275–1292. ISSN 0270-6474. PMC 6381235. PMID 30573646. doi:10.1523/JNEUROSCI.2251-18.2018.
Kamprath, K.; Plendl, W.; Marsicano, G.; Deussing, J. M.; Wurst, W.; Lutz, B.; Wotjak, C. T. (marzo de 2009). "Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling". Genes, Brain and Behavior (en inglés) 8 (2): 203–211. PMID 19077175. doi:10.1111/j.1601-183X.2008.00463.x.
Masneuf, Sophie; Lowery-Gionta, Emily; Colacicco, Giovanni; Pleil, Kristen E.; Li, Chia; Crowley, Nicole; Flynn, Shaun; Holmes, Andrew; Kash, Thomas (outubro de 2014). "Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior". Neuropharmacology (en inglés) 85: 190–197. PMC 4170856. PMID 24796255. doi:10.1016/j.neuropharm.2014.04.015.
Gruden, G; Barutta, F; Kunos, G; Pacher, P (abril de 2016). "Role of the endocannabinoid system in diabetes and diabetic complications: Role of endocannabinoid system in diabetes". British Journal of Pharmacology (en inglés) 173 (7): 1116–1127. PMC 4941127. PMID 26076890. doi:10.1111/bph.13226.
Kimberly, W. Taylor; O'Sullivan, John F.; Nath, Anjali K.; Keyes, Michelle; Shi, Xu; Larson, Martin G.; Yang, Qiong; Long, Michelle T.; Vasan, Ramachandran; Peterson, Randall T.; Wang, Thomas J.; Corey, Kathleen E.; Gerszten, Robert E. (2017-05-04). "Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis". JCI Insight (en inglés) 2 (9): e92989. ISSN 2379-3708. PMC 5414569. PMID 28469090. doi:10.1172/jci.insight.92989.
Habib AM, Okorokov AL, Hill MN, Bras JT, Lee MC, Li S, et al. (agosto de 2019). "Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity". British Journal of Anaesthesia 123 (2): e249–e253. PMC 6676009. PMID 30929760. doi:10.1016/j.bja.2019.02.019.
Police, Anitha; Shankar, Vijay Kumar; Pandey, Pankaj; Rangappa, Srinath; Doerksen, Robert J.; Narasimha Murthy, S. (2023). "Novel topical anandamide formulation for alleviating peripheral neuropathic pain". International Journal of Pharmaceutics 641: 123085. PMID 37245739. doi:10.1016/j.ijpharm.2023.123085.

escholarship.org

di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature (Submitted manuscript) 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Piomelli D (xaneiro de 2004). "THC: moderation during implantation". Nature Medicine 10 (1): 19–20. PMID 14702623. doi:10.1038/nm0104-19.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.

harvard.edu

adsabs.harvard.edu

Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (decembro de 1992). "Isolation and structure of a brain constituent that binds to the cannabinoid receptor". Science 258 (5090): 1946–1949. Bibcode:1992Sci...258.1946D. PMID 1470919. doi:10.1126/science.1470919.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature (Submitted manuscript) 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Fuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P (outubro de 2015). "A runner's high depends on cannabinoid receptors in mice". Proceedings of the National Academy of Sciences of the United States of America 112 (42): 13105–13108. Bibcode:2015PNAS..11213105F. PMC 4620874. PMID 26438875. doi:10.1073/pnas.1514996112.
De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (xullo de 1998). "The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation". Proceedings of the National Academy of Sciences of the United States of America 95 (14): 8375–8380. Bibcode:1998PNAS...95.8375D. PMC 20983. PMID 9653194. doi:10.1073/pnas.95.14.8375.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V (maio de 2001). "Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets". Proceedings of the National Academy of Sciences of the United States of America 98 (11): 6402–6406. Bibcode:2001PNAS...98.6402B. PMC 33480. PMID 11353819. doi:10.1073/pnas.101119098.
Kaczocha M, Glaser ST, Deutsch DG (abril de 2009). "Identification of intracellular carriers for the endocannabinoid anandamide". Proceedings of the National Academy of Sciences of the United States of America 106 (15): 6375–6380. Bibcode:2009PNAS..106.6375K. PMC 2669397. PMID 19307565. doi:10.1073/pnas.0901515106.

jci.org

insight.jci.org

Kimberly, W. Taylor; O'Sullivan, John F.; Nath, Anjali K.; Keyes, Michelle; Shi, Xu; Larson, Martin G.; Yang, Qiong; Long, Michelle T.; Vasan, Ramachandran; Peterson, Randall T.; Wang, Thomas J.; Corey, Kathleen E.; Gerszten, Robert E. (2017-05-04). "Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis". JCI Insight (en inglés) 2 (9): e92989. ISSN 2379-3708. PMC 5414569. PMID 28469090. doi:10.1172/jci.insight.92989.

lww.com

journals.lww.com

Mallet P, Beninger R (maio de 1996). "The endogenous cannabinoid receptor agonist anandamide impairs memory in rats". Behavioural Pharmacology (en inglés) 7 (3): 276–284. ISSN 0955-8810. doi:10.1097/00008877-199605000-00008.

managedhealthcareexecutive.com

"A New Treatment in a New Package for Cutaneous Lupus Erythematosus". 19 de marzo de 2023.

nih.gov

ncbi.nlm.nih.gov

Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. (decembro de 1992). "Isolation and structure of a brain constituent that binds to the cannabinoid receptor". Science 258 (5090): 1946–1949. Bibcode:1992Sci...258.1946D. PMID 1470919. doi:10.1126/science.1470919.
Martin BR, Mechoulam R, Razdan RK (1999). "Discovery and characterization of endogenous cannabinoids". Life Sciences 65 (6–7): 573–595. PMID 10462059. doi:10.1016/S0024-3205(99)00281-7.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature (Submitted manuscript) 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Wang J, Ueda N (setembro de 2009). "Biology of endocannabinoid synthesis system". Prostaglandins & Other Lipid Mediators 89 (3–4): 112–119. PMID 19126434. doi:10.1016/j.prostaglandins.2008.12.002.
Gaetani S, Dipasquale P, Romano A, Righetti L, Cassano T, Piomelli D, Cuomo V (2009). "The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs". International Review of Neurobiology 85: 57–72. ISBN 9780123748935. PMID 19607961. doi:10.1016/S0074-7742(09)85005-8.
Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA (abril de 2010). "Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality". Life Sciences 86 (15–16): 615–623. PMC 2848893. PMID 19527737. doi:10.1016/j.lfs.2009.06.003.
Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Ellington, Heather C; Cotter, Mary A; Cameron, Norman E; Ross, Ruth A (2002-06-01). "The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats". Neuropharmacology (en inglés) 42 (7): 966–975. ISSN 0028-3908. PMID 12069907. doi:10.1016/S0028-3908(02)00040-0.
Silva, M.; Martins, D.; Charrua, A.; Piscitelli, F.; Tavares, I.; Morgado, C.; Di Marzo, V. (2016-08-01). "Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy". Neuropharmacology (en inglés) 107: 49–57. ISSN 0028-3908. PMID 26965218. doi:10.1016/j.neuropharm.2016.03.007.
Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Pacher P, Bátkai S, Kunos G (setembro de 2006). "The endocannabinoid system as an emerging target of pharmacotherapy". Pharmacological Reviews 58 (3): 389–462. PMC 2241751. PMID 16968947. doi:10.1124/pr.58.3.2.
Piomelli D (xaneiro de 2004). "THC: moderation during implantation". Nature Medicine 10 (1): 19–20. PMID 14702623. doi:10.1038/nm0104-19.
El-Talatini MR, Taylor AH, Konje JC (abril de 2010). "The relationship between plasma levels of the endocannabinoid, anandamide, sex steroids, and gonadotrophins during the menstrual cycle". Fertility and Sterility 93 (6): 1989–1996. PMID 19200965. doi:10.1016/j.fertnstert.2008.12.033.
Rapino C, Battista N, Bari M, Maccarrone M (2014). "Endocannabinoids as biomarkers of human reproduction". Human Reproduction Update 20 (4): 501–516. PMID 24516083. doi:10.1093/humupd/dmu004.
Fuss J, Steinle J, Bindila L, Auer MK, Kirchherr H, Lutz B, Gass P (outubro de 2015). "A runner's high depends on cannabinoid receptors in mice". Proceedings of the National Academy of Sciences of the United States of America 112 (42): 13105–13108. Bibcode:2015PNAS..11213105F. PMC 4620874. PMID 26438875. doi:10.1073/pnas.1514996112.
Woodward DF, Liang Y, Krauss AH (febreiro de 2008). "Prostamides (prostaglandin-ethanolamides) and their pharmacology". British Journal of Pharmacology 153 (3): 410–419. PMC 2241799. PMID 17721551. doi:10.1038/sj.bjp.0707434.
De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (xullo de 1998). "The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation". Proceedings of the National Academy of Sciences of the United States of America 95 (14): 8375–8380. Bibcode:1998PNAS...95.8375D. PMC 20983. PMID 9653194. doi:10.1073/pnas.95.14.8375.
di Tomaso E, Beltramo M, Piomelli D (agosto de 1996). "Brain cannabinoids in chocolate". Nature 382 (6593): 677–678. Bibcode:1996Natur.382..677D. PMID 8751435. doi:10.1038/382677a0.
Jeffries KA, Dempsey DR, Behari AL, Anderson RL, Merkler DJ (maio de 2014). "Drosophila melanogaster as a model system to study long-chain fatty acid amide metabolism". FEBS Letters 588 (9): 1596–1602. PMC 4023565. PMID 24650760. doi:10.1016/j.febslet.2014.02.051.
McPartland J, Di Marzo V, De Petrocellis L, Mercer A, Glass M (agosto de 2001). "Cannabinoid receptors are absent in insects". The Journal of Comparative Neurology 436 (4): 423–429. PMID 11447587. doi:10.1002/cne.1078.
Crane NA, Schuster RM, Fusar-Poli P, Gonzalez R (xuño de 2013). "Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences". Neuropsychology Review 23 (2): 117–137. PMC 3593817. PMID 23129391. doi:10.1007/s11065-012-9222-1.
Kregiel J, Malek N, Popik P, Starowicz K, Rygula R (febreiro de 2016). "Anandamide mediates cognitive judgement bias in rats". Neuropharmacology 101: 146–153. PMID 26363193. doi:10.1016/j.neuropharm.2015.09.009.
Calabrese EJ, Rubio-Casillas A (maio de 2018). "Biphasic effects of THC in memory and cognition". European Journal of Clinical Investigation 48 (5): e12920. PMID 29574698. doi:10.1111/eci.12920.
Fantegrossi WE, Wilson CD, Berquist MD (febreiro de 2018). "Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems". Drug Metabolism Reviews 50 (1): 65–73. PMC 6419500. PMID 29385930. doi:10.1080/03602532.2018.1428343.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J (xaneiro de 2020). "Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review". BMC Psychiatry 20 (1): 24. PMC 6966847. PMID 31948424. doi:10.1186/s12888-019-2409-8.
Mahler SV, Smith KS, Berridge KC (novembro de 2007). "Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward". Neuropsychopharmacology 32 (11): 2267–2278. PMID 17406653. doi:10.1038/sj.npp.1301376.
Williams CM, Kirkham TC (xuño de 2002). "Observational analysis of feeding induced by Δ9-THC and anandamide". Physiology & Behavior 76 (2): 241–250. PMID 12044596. doi:10.1016/S0031-9384(02)00725-4.
Natarajan V, Reddy PV, Schmid PC, Schmid HH (agosto de 1982). "N-Acylation of ethanolamine phospholipids in canine myocardium". Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 712 (2): 342–355. PMID 7126608. doi:10.1016/0005-2760(82)90352-6.
Cadas H, di Tomaso E, Piomelli D (febreiro de 1997). "Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain". The Journal of Neuroscience 17 (4): 1226–1242. PMC 6793739. PMID 9006968. doi:10.1523/JNEUROSCI.17-04-01226.1997.
Magotti P, Bauer I, Igarashi M, Babagoli M, Marotta R, Piomelli D, Garau G (marzo de 2015). "Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids". Structure 23 (3): 598–604. PMC 4351732. PMID 25684574. doi:10.1016/j.str.2014.12.018.
Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V (maio de 2001). "Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets". Proceedings of the National Academy of Sciences of the United States of America 98 (11): 6402–6406. Bibcode:2001PNAS...98.6402B. PMC 33480. PMID 11353819. doi:10.1073/pnas.101119098.
Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Bátkai S, et al. (maio de 2005). "Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity". The Journal of Clinical Investigation 115 (5): 1298–1305. PMC 1087161. PMID 15864349. doi:10.1172/JCI23057.
Högestätt ED, Jönsson BA, Ermund A, Andersson DA, Björk H, Alexander JP, et al. (setembro de 2005). "Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system". The Journal of Biological Chemistry 280 (36): 31405–31412. PMID 15987694. doi:10.1074/jbc.M501489200.
Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S (setembro de 2006). "Paracetamol: new vistas of an old drug". CNS Drug Reviews 12 (3–4): 250–275. PMC 6506194. PMID 17227290. doi:10.1111/j.1527-3458.2006.00250.x.
Sinning C, Watzer B, Coste O, Nüsing RM, Ott I, Ligresti A, et al. (decembro de 2008). "New analgesics synthetically derived from the paracetamol metabolite N-(4-hydroxyphenyl)-(5Z,8Z,11Z,14Z)-icosatetra-5,8,11,14-enamide". Journal of Medicinal Chemistry 51 (24): 7800–7805. PMID 19053765. doi:10.1021/jm800807k.
Kaczocha M, Glaser ST, Deutsch DG (abril de 2009). "Identification of intracellular carriers for the endocannabinoid anandamide". Proceedings of the National Academy of Sciences of the United States of America 106 (15): 6375–6380. Bibcode:2009PNAS..106.6375K. PMC 2669397. PMID 19307565. doi:10.1073/pnas.0901515106.
Oddi S, Fezza F, Pasquariello N, D'Agostino A, Catanzaro G, De Simone C, et al. (xuño de 2009). "Molecular identification of albumin and Hsp70 as cytosolic anandamide-binding proteins". Chemistry & Biology 16 (6): 624–632. PMID 19481477. doi:10.1016/j.chembiol.2009.05.004.
Di Scala C, Fantini J, Yahi N, Barrantes FJ, Chahinian H (maio de 2018). "Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter". Biomolecules 8 (2): 31. PMC 6022874. PMID 29789479. doi:10.3390/biom8020031.
Nicolussi S, Viveros-Paredes JM, Gachet MS, Rau M, Flores-Soto ME, Blunder M, Gertsch J (febreiro de 2014). "Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice". Pharmacological Research 80: 52–65. PMID 24412246. doi:10.1016/j.phrs.2013.12.010.
Cernak I, Vink R, Natale J, Stoica B, Lea PM, Movsesyan V, et al. (May 2004). "The "dark side" of endocannabinoids: a neurotoxic role for anandamide". Journal of Cerebral Blood Flow and Metabolism 24 (5): 564–578. PMID 15129189. doi:10.1097/00004647-200405000-00011.
Veldhuis WB, van der Stelt M, Wadman MW, van Zadelhoff G, Maccarrone M, Fezza F, et al. (maio de 2003). "Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases". The Journal of Neuroscience 23 (10): 4127–4133. PMC 6741091. PMID 12764100. doi:10.1523/JNEUROSCI.23-10-04127.2003.
Schulz, Piotr; Hryhorowicz, Szymon; Rychter, Anna Maria; Zawada, Agnieszka; Słomski, Ryszard; Dobrowolska, Agnieszka; Krela-Kaźmierczak, Iwona (2021-01-26). "What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?". Nutrients (en inglés) 13 (2): 373. ISSN 2072-6643. PMC 7911032. PMID 33530406. doi:10.3390/nu13020373.
Morena, Maria; Aukema, Robert J.; Leitl, Kira D.; Rashid, Asim J.; Vecchiarelli, Haley A.; Josselyn, Sheena A.; Hill, Matthew N. (2019-02-13). "Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety". The Journal of Neuroscience (en inglés) 39 (7): 1275–1292. ISSN 0270-6474. PMC 6381235. PMID 30573646. doi:10.1523/JNEUROSCI.2251-18.2018.
Kamprath, K.; Plendl, W.; Marsicano, G.; Deussing, J. M.; Wurst, W.; Lutz, B.; Wotjak, C. T. (marzo de 2009). "Endocannabinoids mediate acute fear adaptation via glutamatergic neurons independently of corticotropin-releasing hormone signaling". Genes, Brain and Behavior (en inglés) 8 (2): 203–211. PMID 19077175. doi:10.1111/j.1601-183X.2008.00463.x.
Masneuf, Sophie; Lowery-Gionta, Emily; Colacicco, Giovanni; Pleil, Kristen E.; Li, Chia; Crowley, Nicole; Flynn, Shaun; Holmes, Andrew; Kash, Thomas (outubro de 2014). "Glutamatergic mechanisms associated with stress-induced amygdala excitability and anxiety-related behavior". Neuropharmacology (en inglés) 85: 190–197. PMC 4170856. PMID 24796255. doi:10.1016/j.neuropharm.2014.04.015.
Gruden, G; Barutta, F; Kunos, G; Pacher, P (abril de 2016). "Role of the endocannabinoid system in diabetes and diabetic complications: Role of endocannabinoid system in diabetes". British Journal of Pharmacology (en inglés) 173 (7): 1116–1127. PMC 4941127. PMID 26076890. doi:10.1111/bph.13226.
Kimberly, W. Taylor; O'Sullivan, John F.; Nath, Anjali K.; Keyes, Michelle; Shi, Xu; Larson, Martin G.; Yang, Qiong; Long, Michelle T.; Vasan, Ramachandran; Peterson, Randall T.; Wang, Thomas J.; Corey, Kathleen E.; Gerszten, Robert E. (2017-05-04). "Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis". JCI Insight (en inglés) 2 (9): e92989. ISSN 2379-3708. PMC 5414569. PMID 28469090. doi:10.1172/jci.insight.92989.
Habib AM, Okorokov AL, Hill MN, Bras JT, Lee MC, Li S, et al. (agosto de 2019). "Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity". British Journal of Anaesthesia 123 (2): e249–e253. PMC 6676009. PMID 30929760. doi:10.1016/j.bja.2019.02.019.
Police, Anitha; Shankar, Vijay Kumar; Pandey, Pankaj; Rangappa, Srinath; Doerksen, Robert J.; Narasimha Murthy, S. (2023). "Novel topical anandamide formulation for alleviating peripheral neuropathic pain". International Journal of Pharmaceutics 641: 123085. PMID 37245739. doi:10.1016/j.ijpharm.2023.123085.

nytimes.com

Murphy H (28 de maro de 2019). "At 71, She's Never Felt Pain or Anxiety. Now Scientists Know Why.". The New York Times. Consultado o 29 de marzo de 2019.

sciencedirect.com

Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Ellington, Heather C; Cotter, Mary A; Cameron, Norman E; Ross, Ruth A (2002-06-01). "The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats". Neuropharmacology (en inglés) 42 (7): 966–975. ISSN 0028-3908. PMID 12069907. doi:10.1016/S0028-3908(02)00040-0.
Silva, M.; Martins, D.; Charrua, A.; Piscitelli, F.; Tavares, I.; Morgado, C.; Di Marzo, V. (2016-08-01). "Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy". Neuropharmacology (en inglés) 107: 49–57. ISSN 0028-3908. PMID 26965218. doi:10.1016/j.neuropharm.2016.03.007.
Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Police, Anitha; Shankar, Vijay Kumar; Pandey, Pankaj; Rangappa, Srinath; Doerksen, Robert J.; Narasimha Murthy, S. (2023). "Novel topical anandamide formulation for alleviating peripheral neuropathic pain". International Journal of Pharmaceutics 641: 123085. PMID 37245739. doi:10.1016/j.ijpharm.2023.123085.

theguardian.com

Sample I (28 de marzo de 2019). "Scientists find genetic mutation that makes woman feel no pain". The Guardian. Consultado o 29 de marzo de 2019.

worldcat.org

Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Ellington, Heather C; Cotter, Mary A; Cameron, Norman E; Ross, Ruth A (2002-06-01). "The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats". Neuropharmacology (en inglés) 42 (7): 966–975. ISSN 0028-3908. PMID 12069907. doi:10.1016/S0028-3908(02)00040-0.
Silva, M.; Martins, D.; Charrua, A.; Piscitelli, F.; Tavares, I.; Morgado, C.; Di Marzo, V. (2016-08-01). "Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy". Neuropharmacology (en inglés) 107: 49–57. ISSN 0028-3908. PMID 26965218. doi:10.1016/j.neuropharm.2016.03.007.
Schreiber, Anne K.; Neufeld, Manuele; Jesus, Carlos H. A.; Cunha, Joice M. (2012-12-01). "Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats". Neuropharmacology (en inglés) 63 (8): 1286–1297. ISSN 0028-3908. PMID 22959964. doi:10.1016/j.neuropharm.2012.08.009.
Mallet P, Beninger R (maio de 1996). "The endogenous cannabinoid receptor agonist anandamide impairs memory in rats". Behavioural Pharmacology (en inglés) 7 (3): 276–284. ISSN 0955-8810. doi:10.1097/00008877-199605000-00008.
Schulz, Piotr; Hryhorowicz, Szymon; Rychter, Anna Maria; Zawada, Agnieszka; Słomski, Ryszard; Dobrowolska, Agnieszka; Krela-Kaźmierczak, Iwona (2021-01-26). "What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?". Nutrients (en inglés) 13 (2): 373. ISSN 2072-6643. PMC 7911032. PMID 33530406. doi:10.3390/nu13020373.
Morena, Maria; Aukema, Robert J.; Leitl, Kira D.; Rashid, Asim J.; Vecchiarelli, Haley A.; Josselyn, Sheena A.; Hill, Matthew N. (2019-02-13). "Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety". The Journal of Neuroscience (en inglés) 39 (7): 1275–1292. ISSN 0270-6474. PMC 6381235. PMID 30573646. doi:10.1523/JNEUROSCI.2251-18.2018.
Kimberly, W. Taylor; O'Sullivan, John F.; Nath, Anjali K.; Keyes, Michelle; Shi, Xu; Larson, Martin G.; Yang, Qiong; Long, Michelle T.; Vasan, Ramachandran; Peterson, Randall T.; Wang, Thomas J.; Corey, Kathleen E.; Gerszten, Robert E. (2017-05-04). "Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis". JCI Insight (en inglés) 2 (9): e92989. ISSN 2379-3708. PMC 5414569. PMID 28469090. doi:10.1172/jci.insight.92989.